Global Dry Powder Inhalation Excipients Market Growth 2024-2030

The global Dry Powder Inhalation Excipients market size is predicted to grow from US$ 1695 million in 2024 to US$ 2351 million in 2030; it is expected to grow at a CAGR of 5.6% from 2024 to 2030.

Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.

United States market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Dry Powder Inhalation Excipients is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Dry Powder Inhalation Excipients players cover Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Dry Powder Inhalation Excipients Industry Forecast” looks at past sales and reviews total world Dry Powder Inhalation Excipients sales in 2023, providing a comprehensive analysis by region and market sector of projected Dry Powder Inhalation Excipients sales for 2024 through 2030. With Dry Powder Inhalation Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Powder Inhalation Excipients industry.

This Insight Report provides a comprehensive analysis of the global Dry Powder Inhalation Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Powder Inhalation Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dry Powder Inhalation Excipients market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Powder Inhalation Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Powder Inhalation Excipients.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhalation Excipients market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Lactose
Magnesium Stearate
Others

Segmentation by Application:
DPI
MDI
Nebulizer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Protheragen-ING
DFE Pharma
Meggle-Pharma
Pfanstiehl
Merck
Sheffield (Kerry)
Armor Pharma
Abbott
Norvatis
Bayer
Jiangsu Daoning Drug

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dry Powder Inhalation Excipients market?

What factors are driving Dry Powder Inhalation Excipients market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dry Powder Inhalation Excipients market opportunities vary by end market size?

How does Dry Powder Inhalation Excipients break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.